IMARC Group, a leading market research company, has recently releases report titled “Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global oligonucleotide synthesis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big is the Oligonucleotide Synthesis Market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.7 Billion |
| Market Forecast in 2028 | US$ 5.5 Billion |
| Growth rate (2023 to 2028) | CAGR of 12.76% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is Oligonucleotide Synthesis?
Oligonucleotide synthesis represents chemical procedures in which short fragments of nucleic acids are linked to form desired sequenced products. They can be customized by researchers according to their application and requirements. Oligonucleotide synthesis processes are primers and probes in recombinant DNA technologies for developing monoclonal antibodies. They are even utilized for gene expression, genetic disease screening, cloning, molecular diagnostics, etc. As a result, oligonucleotide synthesis systems find extensive applications in pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, academic research institutes, etc.
Request for a Free PDF Sample Report: https://www.imarcgroup.com/oligonucleotide-synthesis-market/requestsample
What Are the Growth Prospects and Trends in the Oligonucleotide Synthesis Market?
The elevating production of mRNA and DNA vaccines, on account of the increasing urgency for potential treatments to control the sudden outbreak of the COVID-19 pandemic, is primarily driving the oligonucleotide synthesis market. In addition to this, the expanding incidences of cancer and other chronic diseases and the rising need for novel diagnostics are acting as significant growth-inducing factors. Apart from this, the shifting preferences toward personalized medicines and the introduction of automated reactor platforms that offer access to oligonucleotides at reasonable prices are also positively influencing the global market. In line with this, the escalating advancements in purification and quality control technologies that help reduce the overall cost of oligonucleotide techniques while substantially improving quality and yield are further stimulating the market growth. Moreover, the inflating investments in research and development (R&D) activities and the growing number of clinical trials related to several oligonucleotide-based therapies that will help treat viral infections, neuromuscular conditions, and rare genetic disorders are anticipated to propel the oligonucleotide synthesis market over the forecasted period.
Who Are the Key Players Operating in the Oligonucleotide Synthesis Market?
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Agilent Technologies Inc.
- Biolegio B.V.
- Bio-Synthesis Inc
- Eurofins Genomics
- GenScript
- Horizon Discovery Ltd
- Integrated DNA Technologies Inc (Danaher Corporation)
- Kaneka Eurogentec S.A. (Kaneka Corporation)
- LGC Limited
- Nitto Denko Avecia Inc (Nitto Denko Corporation)
- Thermo Fisher Scientific Inc.
What is Included in Market Segmentation?
The report has categorized the market based on product, application, end useand region.
Breakup by Product:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
Breakup by Application:
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In-Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
